AllNewsChannels.com

New Data Transforms Outlook on Hormonal Treatment for Menopause, Challenging Past Concerns

Recent developments have led to a reassessment of hormonal treatment for menopause, shifting the perspective on its risks and benefits. Over two decades ago, a study significantly altered the perception of hormone replacement therapy (HRT) for menopausal women, highlighting potential risks such as breast cancer and cardiovascular disease. However, new data suggests that the early findings may have been flawed, and under certain conditions, HRT could offer protective benefits against cardiovascular disease and osteoporosis without the previously believed high risks. This reevaluation encourages a more nuanced approach to HRT, considering factors such as the method of administration and the timing of treatment.

  • Menopause is a natural process marked by the end of menstrual cycles and a significant drop in hormone levels, leading to various symptoms like hot flashes, night sweats, sleeping disorders, and memory loss.
  • In 2002, a study by the Women’s Health Initiative linked hormone replacement therapy (HRT) for menopause to an increased risk of breast cancer and cardiovascular diseases, causing a drastic decline in its use.
  • Before the 2002 study, 60% of menopausal women in France utilized HRT, a number that plummeted to 5% post-study and has since slightly recovered to 8-10%.
  • Recent studies suggest the 2002 findings were flawed, primarily because it involved women who were older and already at an increased risk of vascular issues. Newer research indicates that if HRT is administered earlier and for a limited period, it could protect against cardiovascular disease and osteoporosis.
  • Methods of HRT administration play a crucial role in its safety and efficacy. For example, in France, HRT is often administered dermally (through the skin), which is believed to pose less risk compared to oral administration that can affect blood clotting via liver processing.

France 24 is an international television network and news website owned by the French state.

Official website: https://www.france24.com/en/

Original video here.

This summary has been generated by AI.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *